The combination of elesclomol and Cu2+ can inhibit the growth of colon cancer cells by targeting FDX1
Jing Yu(Shanxi Medical University), Manzhao Ouyang(The First People's Hospital of Shunde), Kang Wang(The First People's Hospital of Shunde), Yuanhong Peng(The First People's Hospital of Shunde), Haibin Li(Guangxi Medical University), Yan Lü(Columbia University), Qihuan Xu(The First People's Hospital of Shunde)
Cited by 0
Related Papers
Vascular and inflammatory stresses mediate atherosclerosis via RAGE and its ligands in apoE–/– mice
|Journal of Clinical Investigation|2008|363
Receptor for Advanced-Glycation End Products
|Circulation|2006|250
Deletion of the Receptor for Advanced Glycation End Products Reduces Glomerulosclerosis and Preserves Renal Function in the Diabetic OVE26 Mouse
|Diabetes|2010|175
Blockade of receptor for advanced glycation endproducts: a new target for therapeutic intervention in diabetic complications and inflammatory disorders
|Archives of Biochemistry and Biophysics|2003|165
Artificial intelligence-based MRI radiomics and radiogenomics in glioma
|Cancer Imaging|2024|97